LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 180

Search options

  1. Article ; Online: Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19.

    Chang, Aiquan / Yu, Jingyou

    Viruses

    2022  Volume 14, Issue 2

    Abstract: The persistent expansion of the coronavirus disease 2019 (COVID-19) global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the rapid development of safe and effective countermeasures to reduce transmission, ... ...

    Abstract The persistent expansion of the coronavirus disease 2019 (COVID-19) global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the rapid development of safe and effective countermeasures to reduce transmission, morbidity, and mortality. Several highly efficacious vaccines are actively being deployed around the globe to expedite mass vaccination and control of COVID-19. Notably, viral vectored vaccines (VVVs) are among the first to be approved for global distribution and use. In this review, we examine the humoral, cellular, and innate immune responses elicited by viral vectors, and the immune correlates of protection against COVID-19 in preclinical and clinical studies. We also discuss the durability and breadth of immune response induced by VVVs and boosters. Finally, we present challenges associated with VVVs and offer solutions for overcoming certain limitations of current vaccine regimens. Collectively, this review provides the rationale for expanding the portfolio of VVVs against SARS-CoV-2.
    MeSH term(s) Animals ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; COVID-19/immunology ; COVID-19/prevention & control ; COVID-19 Vaccines/genetics ; COVID-19 Vaccines/immunology ; Clinical Trials as Topic ; Disease Models, Animal ; Genetic Vectors/immunology ; Immunity, Cellular ; Immunity, Humoral ; Immunity, Innate ; Immunization, Secondary ; Immunogenicity, Vaccine ; SARS-CoV-2/immunology ; Spike Glycoprotein, Coronavirus/genetics ; Vaccination ; Viral Vaccines/classification ; Viral Vaccines/genetics ; Viral Vaccines/immunology
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral ; COVID-19 Vaccines ; Spike Glycoprotein, Coronavirus ; Viral Vaccines
    Language English
    Publishing date 2022-02-12
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v14020380
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19

    Chang, Aiquan / Yu, Jingyou

    Viruses. 2022 Feb. 12, v. 14, no. 2

    2022  

    Abstract: The persistent expansion of the coronavirus disease 2019 (COVID-19) global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the rapid development of safe and effective countermeasures to reduce transmission, ... ...

    Abstract The persistent expansion of the coronavirus disease 2019 (COVID-19) global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the rapid development of safe and effective countermeasures to reduce transmission, morbidity, and mortality. Several highly efficacious vaccines are actively being deployed around the globe to expedite mass vaccination and control of COVID-19. Notably, viral vectored vaccines (VVVs) are among the first to be approved for global distribution and use. In this review, we examine the humoral, cellular, and innate immune responses elicited by viral vectors, and the immune correlates of protection against COVID-19 in preclinical and clinical studies. We also discuss the durability and breadth of immune response induced by VVVs and boosters. Finally, we present challenges associated with VVVs and offer solutions for overcoming certain limitations of current vaccine regimens. Collectively, this review provides the rationale for expanding the portfolio of VVVs against SARS-CoV-2.
    Keywords COVID-19 infection ; Severe acute respiratory syndrome coronavirus 2 ; durability ; geographical distribution ; immune response ; immunogenicity ; morbidity ; mortality ; pandemic ; vaccination ; vaccines
    Language English
    Dates of publication 2022-0212
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2516098-9
    ISSN 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v14020380
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article ; Online: Omicron breakthrough infected individuals show enhanced nasal antibody responses and preserved T cell responses against the EG.5.1 and BA.2.86.

    Zhu, Zheng / Li, Shixiong / Fan, Junhao / Shang, Shihao / Zhang, Yao / Zi, Qiong / Zheng, Jihao / Wang, Dongfang / Mou, Xiaoli / Liu, Kepu / Lv, Maoxin / Yuan, Jianlin / Wang, Zhongfang / Yu, Jingyou

    Journal of medical virology

    2024  Volume 96, Issue 3, Page(s) e29537

    MeSH term(s) Humans ; Antibody Formation ; T-Lymphocytes
    Language English
    Publishing date 2024-03-18
    Publishing country United States
    Document type Letter
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.29537
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Emerging Role of LY6E in Virus-Host Interactions.

    Yu, Jingyou / Liu, Shan-Lu

    Viruses

    2019  Volume 11, Issue 11

    Abstract: As a canonical lymphocyte antigen-6/urokinase-type plasminogen activator receptor Ly6/uPAR family protein, lymphocyte antigen 6 complex, locus E (LY6E), plays important roles in immunological regulation, T cell physiology, and oncogenesis. Emerging ... ...

    Abstract As a canonical lymphocyte antigen-6/urokinase-type plasminogen activator receptor Ly6/uPAR family protein, lymphocyte antigen 6 complex, locus E (LY6E), plays important roles in immunological regulation, T cell physiology, and oncogenesis. Emerging evidence indicates that LY6E is also involved in the modulation of viral infection. Consequently, viral infection and associated pathogenesis have been associated with altered LY6E gene expression. The interaction between viruses and the host immune system has offered insights into the biology of LY6E. In this review, we summarize the current knowledge of LY6E in the context of viral infection, particularly viral entry.
    MeSH term(s) Animals ; Antigens, Surface/genetics ; Antigens, Surface/metabolism ; Antigens, Surface/physiology ; GPI-Linked Proteins/genetics ; GPI-Linked Proteins/metabolism ; GPI-Linked Proteins/physiology ; Host-Pathogen Interactions ; Humans ; Receptors, Cell Surface/metabolism ; Species Specificity ; Virus Diseases/metabolism ; Virus Diseases/virology ; Virus Internalization ; Virus Physiological Phenomena ; Viruses/classification ; Viruses/metabolism
    Chemical Substances Antigens, Surface ; GPI-Linked Proteins ; LY6E protein, human ; Receptors, Cell Surface
    Language English
    Publishing date 2019-11-03
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v11111020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Emerging Role of LY6E in Virus–Host Interactions

    Yu, Jingyou / Liu, Shan-Lu

    Viruses. 2019 Nov. 03, v. 11, no. 11

    2019  

    Abstract: As a canonical lymphocyte antigen-6/urokinase-type plasminogen activator receptor Ly6/uPAR family protein, lymphocyte antigen 6 complex, locus E (LY6E), plays important roles in immunological regulation, T cell physiology, and oncogenesis. Emerging ... ...

    Abstract As a canonical lymphocyte antigen-6/urokinase-type plasminogen activator receptor Ly6/uPAR family protein, lymphocyte antigen 6 complex, locus E (LY6E), plays important roles in immunological regulation, T cell physiology, and oncogenesis. Emerging evidence indicates that LY6E is also involved in the modulation of viral infection. Consequently, viral infection and associated pathogenesis have been associated with altered LY6E gene expression. The interaction between viruses and the host immune system has offered insights into the biology of LY6E. In this review, we summarize the current knowledge of LY6E in the context of viral infection, particularly viral entry.
    Keywords T-lymphocytes ; antigens ; carcinogenesis ; cell physiology ; gene expression ; host-pathogen relationships ; loci ; u-plasminogen activator ; viruses
    Language English
    Dates of publication 2019-1103
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2516098-9
    ISSN 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v11111020
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Muscle-inspired soft robots based on bilateral dielectric elastomer actuators.

    Yang, Yale / Li, Dengfeng / Sun, Yanhua / Wu, Mengge / Su, Jingyou / Li, Ying / Yu, Xinge / Li, Lu / Yu, Junsheng

    Microsystems & nanoengineering

    2023  Volume 9, Page(s) 124

    Abstract: Muscle groups perform their functions in the human body via bilateral muscle actuation, which brings bionic inspiration to artificial robot design. Building soft robotic systems with artificial muscles and multiple control dimensions could be an ... ...

    Abstract Muscle groups perform their functions in the human body via bilateral muscle actuation, which brings bionic inspiration to artificial robot design. Building soft robotic systems with artificial muscles and multiple control dimensions could be an effective means to develop highly controllable soft robots. Here, we report a bilateral actuator with a bilateral deformation function similar to that of a muscle group that can be used for soft robots. To construct this bilateral actuator, a low-cost VHB 4910 dielectric elastomer was selected as the artificial muscle, and polymer films manufactured with specific shapes served as the actuator frame. By end-to-end connecting these bilateral actuators, a gear-shaped 3D soft robot with diverse motion capabilities could be developed, benefiting from adjustable actuation combinations. Lying on the ground with all feet on the ground, a crawling soft robot with dexterous movement along multiple directions was realized. Moreover, the directional steering was instantaneous and efficient. With two feet standing on the ground, it also acted as a rolling soft robot that can achieve bidirectional rolling motion and climbing motion on a 2° slope. Finally, inspired by the orbicularis oris muscle in the mouth, a mouthlike soft robot that could bite and grab objects 5.3 times of its body weight was demonstrated. The bidirectional function of a single actuator and the various combination modes among multiple actuators together allow the soft robots to exhibit diverse functionalities and flexibility, which provides a very valuable reference for the design of highly controllable soft robots.
    Language English
    Publishing date 2023-10-07
    Publishing country England
    Document type Journal Article
    ISSN 2055-7434
    ISSN (online) 2055-7434
    DOI 10.1038/s41378-023-00592-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Attenuated

    Vidal, Samuel J / Sellers, Daniel / Yu, Jingyou / Wakabayashi, Shoko / Sixsmith, Jaimie / Aid, Malika / Barrett, Julia / Stevens, Sage F / Liu, Xiaowen / Li, Wenjun / Plumlee, Courtney R / Urdahl, Kevin B / Martinot, Amanda J / Barouch, Dan H

    iScience

    2023  Volume 26, Issue 6, Page(s) 106963

    Abstract: Bacillus Calmette-Guérin (BCG) remains the only approved tuberculosis (TB) vaccine despite limited efficacy. Preclinical studies of next-generation TB vaccines typically use a murine aerosol model with a supraphysiologic challenge dose. Here, we show ... ...

    Abstract Bacillus Calmette-Guérin (BCG) remains the only approved tuberculosis (TB) vaccine despite limited efficacy. Preclinical studies of next-generation TB vaccines typically use a murine aerosol model with a supraphysiologic challenge dose. Here, we show that the protective efficacy of a live attenuated
    Language English
    Publishing date 2023-05-28
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2023.106963
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Approaches and Challenges in SARS-CoV-2 Vaccine Development

    Dagotto, Gabriel / Yu, Jingyou / Barouch, Dan H.

    Cell Host & Microbe

    2020  Volume 28, Issue 3, Page(s) 364–370

    Keywords Microbiology ; Parasitology ; Virology ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2278004-X
    ISSN 1931-3128
    ISSN 1931-3128
    DOI 10.1016/j.chom.2020.08.002
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Approaches and Challenges in SARS-CoV-2 Vaccine Development.

    Dagotto, Gabriel / Yu, Jingyou / Barouch, Dan H

    Cell host & microbe

    2020  Volume 28, Issue 3, Page(s) 364–370

    Abstract: The explosive spread of SARS-CoV-2 suggests that a vaccine will be required to end this global pandemic. Progress in SARS-CoV-2 vaccine development to date has been faster than for any other pathogen in history. Multiple SARS-CoV-2 vaccine candidates ... ...

    Abstract The explosive spread of SARS-CoV-2 suggests that a vaccine will be required to end this global pandemic. Progress in SARS-CoV-2 vaccine development to date has been faster than for any other pathogen in history. Multiple SARS-CoV-2 vaccine candidates have been evaluated in preclinical models and are currently in clinical trials. In this Perspective, we discuss three topics that are critical for SARS-CoV-2 vaccine development: antigen selection and engineering, preclinical challenge studies in non-human primate models, and immune correlates of protection.
    MeSH term(s) Animals ; Antigens, Viral/chemistry ; Antigens, Viral/genetics ; Betacoronavirus/genetics ; Betacoronavirus/immunology ; COVID-19 ; COVID-19 Vaccines ; Coronavirus Infections/epidemiology ; Coronavirus Infections/immunology ; Coronavirus Infections/prevention & control ; Host Microbial Interactions/immunology ; Humans ; Immunity, Cellular ; Immunity, Humoral ; Immunity, Innate ; Models, Animal ; Pandemics/prevention & control ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/immunology ; Pneumonia, Viral/prevention & control ; Primates ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/immunology ; Viral Vaccines/administration & dosage ; Viral Vaccines/immunology ; Viral Vaccines/isolation & purification
    Chemical Substances Antigens, Viral ; COVID-19 Vaccines ; Spike Glycoprotein, Coronavirus ; Viral Vaccines ; spike protein, SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-08-10
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2278004-X
    ISSN 1934-6069 ; 1931-3128
    ISSN (online) 1934-6069
    ISSN 1931-3128
    DOI 10.1016/j.chom.2020.08.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.

    Yu, Jingyou / Liu, Shan-Lu

    Viruses

    2018  Volume 10, Issue 8

    Abstract: Interferon inducible transmembrane proteins (IFITMs) are one of several IFN-stimulated genes (ISGs) that restrict entry of enveloped viruses, including flaviviruses, filoviruses and retroviruses. It has been recently reported that in U87 glioblastoma ... ...

    Abstract Interferon inducible transmembrane proteins (IFITMs) are one of several IFN-stimulated genes (ISGs) that restrict entry of enveloped viruses, including flaviviruses, filoviruses and retroviruses. It has been recently reported that in U87 glioblastoma cells IFITM proteins inhibit HIV-1 entry in a co-receptor-dependent manner, that is, IFITM1 is more inhibitory on CCR5 tropic HIV-1 whereas IFITM2/3 confers a greater suppression of CXCR4 counterparts. However, how entry of HIV-1 with distinct co-receptor usage is modulated by different IFITM orthologs in physiologically relevant CD4⁺ T cells and monocytes/macrophages has not been investigated in detail. Here, we report that overexpression of IFITM1, 2 and 3 in human CD4⁺ HuT78 cells, SupT1 cells, monocytic THP-1 cells and U87 cells expressing CD4 and co-receptor CCR5 or CXCR4, suppressed entry of CXCR4 tropic viruses NL4.3 and HXB2, CCR5 tropic viruses AD8 and JRFL, dual tropic 89.6 virus, as well as a panel of 32 transmitted founder (T/F) viruses, with a consistent order of potency, that is, IFITM3 > IFITM2 > IFITM1. Consistent with previous reports, we found that some CCR5-using HIV-1 isolates, such as AD8 and JRFL, were relatively resistant to inhibition by IFITM2 and IFITM3, although the effect can be cell-type dependent. However, in no case have we observed that IFITM1 had a stronger inhibition on entry of any HIV-1 strains tested, including those of CCR5-using T/Fs. We knocked down the endogenous IFITMs in peripheral blood mononuclear cells (PBMCs) and purified CD4⁺ T cells and observed that, while this treatment did greatly enhance the multiple-round of HIV-1 replication but had modest effect to rescue the single-round HIV-1 infection, reinforcing our previous conclusion that the predominant effect of IFITMs on HIV-1 infection is in viral producer cells, rather than in target cells to block viral entry. Overall, our results argue against the idea that IFITM proteins distinguish co-receptors CCR5 and CXCR4 to inhibit entry but emphasize that the predominant role of IFITMs on HIV-1 is in producer cells that intrinsically impair the viral infectivity.
    MeSH term(s) Antigens, Differentiation/genetics ; CD4-Positive T-Lymphocytes/virology ; Cell Line ; Gene Knockdown Techniques ; HIV-1/physiology ; Humans ; Membrane Proteins/genetics ; RNA, Small Interfering ; RNA-Binding Proteins/genetics ; Receptors, CCR5/genetics ; Receptors, CCR5/physiology ; Receptors, CXCR4/genetics ; Receptors, CXCR4/physiology ; Receptors, Virus/genetics ; Receptors, Virus/physiology ; THP-1 Cells ; Virus Internalization
    Chemical Substances Antigens, Differentiation ; CCR5 protein, human ; CXCR4 protein, human ; IFITM2 protein, human ; IFITM3 protein, human ; Membrane Proteins ; RNA, Small Interfering ; RNA-Binding Proteins ; Receptors, CCR5 ; Receptors, CXCR4 ; Receptors, Virus ; leu-13 antigen
    Keywords covid19
    Language English
    Publishing date 2018-08-07
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v10080413
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top